Certificate

Brand

NGenebio

Product Type

Instrument

Highlights

This is a precision diagnosis panel to detect major genetic variations related to malignant tumors in blood using NGS technology.

Specifications

Certification Korean Ministry of Food and Drug Safety (MFDS) license of in-vitro diagnostic device manufacturing (License No. 20-398)
CE-IVD
Compatible platforms Illumina / MiSeq, MiSeq Dx
Target enrichment Targeted sequencing / Hyb & capture method
Specimen Blood, bone marrow and lymph nodes
Quantity 96 tests/kit (8 runs per kit, up to 12 samples per run)
Target genes 108 genes
Target size 305 kb
Turn around time 2 ~ 3 days
Variants type SNV, INDEL
Analysis solution NGeneAnalySys™

Related Products

TruSight Tumor 26

TruSight Tumor 26 Kit include reagents to prepare for Library preparation samples, sequencing 26 genes relating to solid cancer, variant of  soma in NGS – Next Generation Sequencing of Illumina

Next Generation Sequencing System – MiSeq

Model: MiSeq
Manufacturer: Illumina/USA
– The MiSeq System combines cluster generation, amplification, sequencing and data analysis on a single system
– The system is most widely used, with next-generation sequencing technology –  Sequencing by Synthesis – SBS